Day: March 24, 2026

HONG KONG — March 23, 2026 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of PandaClaw, a transformative new feature of the PandaOmics engine that combines AI agents with biological and bioinformatics workflows. By automating complex real-time analyses, the tool enables researchers to …